Cystic fibrosis related liver disease and endocrine considerations.
J Clin Transl Endocrinol
; 27: 100283, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35024343
APRI, aspartate aminotransferase to platelet ratio; BMI, body mass index; CFBD, CF bone disease; CFLD, Cystic fibrosis-liver disease; CFRD, CF related diabetes; CFTR, cystic fibrosis transmembrane conductance regulator; Cirrhosis; Cystic fibrosis liver disease; Cystic fibrosis-related diabetes; FFA, free fatty acids; Fib-4, Fibrosis-4; GH, growth hormone; IGF-1, insulin-like growth factor-1; Insulin resistance; UDCA, ursodeoxycholic acid; ULN, upper limit of normal
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
J Clin Transl Endocrinol
Year:
2022
Document type:
Article
Affiliation country:
United States